93 related articles for article (PubMed ID: 17074933)
1. Extending contingency management to the treatment of methamphetamine use disorders.
Higgins ST
Am J Psychiatry; 2006 Nov; 163(11):1870-2. PubMed ID: 17074933
[No Abstract] [Full Text] [Related]
2. Contingency management: an evidence-based component of methamphetamine use disorder treatments.
Roll JM
Addiction; 2007 Apr; 102 Suppl 1():114-20. PubMed ID: 17493060
[TBL] [Abstract][Full Text] [Related]
3. Contingency management for the treatment of methamphetamine use disorders.
Roll JM; Petry NM; Stitzer ML; Brecht ML; Peirce JM; McCann MJ; Blaine J; MacDonald M; DiMaria J; Lucero L; Kellogg S
Am J Psychiatry; 2006 Nov; 163(11):1993-9. PubMed ID: 17074952
[TBL] [Abstract][Full Text] [Related]
4. Contingency management interventions: from research to practice.
Petry NM; Petrakis I; Trevisan L; Wiredu G; Boutros NN; Martin B; Kosten TR
Am J Psychiatry; 2001 May; 158(5):694-702. PubMed ID: 11329388
[No Abstract] [Full Text] [Related]
5. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
Obert JL; Brown AH; Zweben J; Christian D; Delmhorst J; Minsky S; Morrisey P; Vandersloot D; Weiner A
J Subst Abuse Treat; 2005 Apr; 28(3):231-7. PubMed ID: 15857723
[TBL] [Abstract][Full Text] [Related]
6. Contingency management for the treatment of methamphetamine use disorder: A systematic review.
Brown HD; DeFulio A
Drug Alcohol Depend; 2020 Nov; 216():108307. PubMed ID: 33007699
[TBL] [Abstract][Full Text] [Related]
7. Contingency management: utility in the treatment of drug abuse disorders.
Stitzer ML; Vandrey R
Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
[TBL] [Abstract][Full Text] [Related]
8. A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence.
Shoptaw S; Klausner JD; Reback CJ; Tierney S; Stansell J; Hare CB; Gibson S; Siever M; King WD; Kao U; Dang J
BMC Public Health; 2006 Aug; 6():214. PubMed ID: 16919170
[TBL] [Abstract][Full Text] [Related]
9. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
Shoptaw S; Reback CJ; Peck JA; Yang X; Rotheram-Fuller E; Larkins S; Veniegas RC; Freese TE; Hucks-Ortiz C
Drug Alcohol Depend; 2005 May; 78(2):125-34. PubMed ID: 15845315
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial treatment for methamphetamine use disorders: a preliminary randomized controlled trial of cognitive behavior therapy and Acceptance and Commitment Therapy.
Smout MF; Longo M; Harrison S; Minniti R; Wickes W; White JM
Subst Abus; 2010 Apr; 31(2):98-107. PubMed ID: 20408061
[TBL] [Abstract][Full Text] [Related]
11. Interventions to Reduce Drug Use Among Methamphetamine Users at Risk for HIV.
Corsi KF; Shoptaw S; Alishahi M; Booth RE
Curr HIV/AIDS Rep; 2019 Feb; 16(1):29-36. PubMed ID: 30761465
[TBL] [Abstract][Full Text] [Related]
12. Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service.
Kellogg SH; Burns M; Coleman P; Stitzer M; Wale JB; Kreek MJ
J Subst Abuse Treat; 2005 Jan; 28(1):57-65. PubMed ID: 15723733
[TBL] [Abstract][Full Text] [Related]
13. A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence.
Farronato NS; Dürsteler-Macfarland KM; Wiesbeck GA; Petitjean SA
J Addict Dis; 2013; 32(3):274-87. PubMed ID: 24074193
[TBL] [Abstract][Full Text] [Related]
14. Contingency management for treatment of substance abuse.
Stitzer M; Petry N
Annu Rev Clin Psychol; 2006; 2():411-34. PubMed ID: 17716077
[TBL] [Abstract][Full Text] [Related]
15. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
[TBL] [Abstract][Full Text] [Related]
16. The clinical characteristics of adolescents reporting methamphetamine as their primary drug of choice: an examination of youth admitted to inpatient substance-abuse treatment in northern British Columbia, Canada, 2001-2005.
Callaghan RC; Brands B; Taylor L; Lentz T
J Adolesc Health; 2007 Mar; 40(3):286-9. PubMed ID: 17321434
[TBL] [Abstract][Full Text] [Related]
17. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL
Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-Related Disorders.
Gouzoulis-Mayfrank E; Härtel-Petri R; Hamdorf W; Havemann-Reinecke U; Mühlig S; Wodarz N
Dtsch Arztebl Int; 2017 Jun; 114(26):455-461. PubMed ID: 28705298
[TBL] [Abstract][Full Text] [Related]
20. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program.
Jaffe A; Shoptaw S; Stein J; Reback CJ; Rotheram-Fuller E
Exp Clin Psychopharmacol; 2007 Jun; 15(3):301-7. PubMed ID: 17563217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
